Oncologists across Las Vegas are sounding the alarm: cancers that used to be mostly an older person’s problem are now increasingly showing up in people in their 20s, 30s and 40s. Local cancer specialists say they are spotting tumors at later stages and with biology that does not always match what they expect for younger adults, pushing them to have more urgent conversations about screening and taking persistent symptoms seriously. The shift is already changing how Southern Nevada doctors respond when younger patients come in with abdominal pain, unexplained weight loss or rectal bleeding.
As reported by 8NewsNow, Dr. Russell Gollard, medical director at Optum Cancer Care in Las Vegas, said cancer diagnoses have been steadily climbing among people in their 20s, 30s and 40s. Clinicians are seeing kidney, pancreatic and small‑intestine tumors earlier in life than they used to. He told the outlet that colorectal cancer has moved up the list as a cause of cancer death among men under 50, and that physicians are pressing younger adults not to shrug off warning signs. Local oncologists say family history and a lower bar for ordering tests are becoming central parts of their decision‑making.
National data mirror local concerns
A large American Cancer Society–led analysis published in Lancet Public Health found that people born in more recent decades have higher incidence for 17 of 34 common cancers compared with older generations. The study highlighted especially steep increases in small‑intestine, kidney and pancreatic cancers in the youngest birth cohorts, closely matching what Las Vegas oncologists report seeing in clinics. The authors and outside experts say these birth‑cohort patterns point to factors acting earlier in life and call for targeted research into what is driving the trend.
Possible drivers and detection effects
Public health researchers have flagged rising obesity, heavy consumption of ultra‑processed foods and more sedentary daily life as plausible pieces of the puzzle, though none of them fully account for the pattern by themselves. A broad review of U.S. cancer data in Cancer Statistics, 2025 also notes that increased diagnostic scrutiny and incidental findings probably explain part of the rise for some cancers, while others appear more tightly linked to metabolic or environmental risks. Experts say that sorting out biological causes from detection effects will take coordinated research and better information on exposures early in life.
What doctors are recommending about screening
Because early‑onset colorectal cancer has been climbing, national guidelines now call for average‑risk adults to start colorectal screening at 45, a change the U.S. Preventive Services Task Force formalized in 2021. Clinicians also recommend that anyone with a family history of cancer talk with their provider about starting earlier or tailoring the type of screening. The American Cancer Society urges individualized conversations about timing and test options. Doctors emphasize that catching cancer early, whether through stool‑based tests, colonoscopy or imaging when it is indicated, is still the best shot at preventing deaths from many of these diseases.
Red flags and local options
Physicians are urging younger patients to speak up if they notice persistent rectal bleeding, unexplained weight loss, changes in bowel habits or ongoing abdominal pain, and to push for evaluation rather than accepting reassurance based on age alone. The Centers for Disease Control and Prevention stresses that screening can find precancerous growths and that anyone 45 or older should be up to date on colorectal screening. Local clinics and community health centers can help patients sort through options and insurance coverage.
Researchers say the emerging pattern of earlier, sometimes more aggressive cancers is almost certainly driven by multiple factors. They point to community‑level prevention efforts, wider access to screening and more funding for birth‑cohort research as key to softening what could become a heavier cancer burden for younger adults. The trends laid out in the Lancet Public Health analysis make clear that what Las Vegas doctors are seeing is part of a larger national question that will shape cancer prevention and screening strategies for years to come.
